Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - amoxicillin trihydrate -

Marekani - Kiingereza - NLM (National Library of Medicine)

ranbaxy laboratories limited - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - solution - 10 mg in 5 ml - nortriptyline hydrochloride is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the concurrent use of nortriptyline hydrochloride or other tricyclic antidepressants with a monoamine oxidase (mao) inhibitor is contraindicated. hyperpyretic crises, severe convulsions, and fatalities have occurred when similar tricyclic antidepressants were used in such combinations. it is advisable to discontinue the mao inhibitor at least 2 weeks before treatment with nortriptyline hydrochloride is to be started. patients hypersensitive to nortriptyline hydrochloride should not be given the drug. cross-sensitivity between nortriptyline hydrochloride and other dibenzazepines is a possibility. nortriptyline hydrochloride is contraindicated during the acute recovery period after myocardial infarction.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lisinopril dihydrate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lisinopril dihydrate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - lisinopril dihydrate -

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ranbaxy (uk) (5) ltd. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem

Ubelgiji - Kiingereza - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ranbaxy (uk) (5) ltd. - meropenem trihydrate 1140 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem

Afrika Kusini - Kiingereza - South African Health Products Regulatory Authority (SAHPRA)

ranbaxy pharmaceutical (pty) ltd û roodepoort - tablet - see ingredients - each tablet contains diazepam 5,0 mg

Afrika Kusini - Kiingereza - South African Health Products Regulatory Authority (SAHPRA)

ranbaxy pharmaceutical (pty) ltd û roodepoort - tablet - see ingredients - each tablet contains aciclovir 200,0 mg